On May 3, 2017, the Center for Strategic and International Studies (CSIS) and the Japan Center for International Exchange (JCIE) co-hosted a half day meeting exploring how the Trump and Abe Administrations can continue and strengthen the two countries’ longstanding partnership in global health. Several points came up during the meeting that were largely agreed upon by both U.S. and Japanese participants. These included:
The Need for Sustained U.S. Leadership in Global Health
Senior members from the Japanese delegation stressed the need for sustained U.S. leadership in global health emanating from the executive branch. Participants pointed to the tremendous impact of U.S. engagement in global health over the past decade—including the successes of U.S.-led initiatives like PEPFAR and the President’s Malaria Initiative (PMI), as well as contributions to multilateral efforts such as Gavi, the Vaccine Alliance and the Global Fund—and cautioned that a retreat in American funding and political leadership would undermine many of these hard-fought gains.
Better Evaluating the Impact of Global Health Investments
Sustaining support for U.S. engagement in global health will require better evaluative efforts moving forward. Noting the current political climate in Washington, participants emphasized the need for greater oversight of federal investments in global health and improved methods for measuring their intended impact. Such efforts would hopefully yield both increased accountability and efficacy of increasingly scarce tax dollars and help maintain political support for global health endeavors in a time of retrenchment and increasing budgetary pressures around the world.
Building Bilateral Cooperation on Matters of Global Health Security
An over-arching theme from the day’s discussions was the potential value of launching a U.S.-Japan cooperative initiative on global health security as a pillar of the broader bilateral relationship. This initiative would focus on building consensus and outlining concrete steps for collaborative action on issues of shared importance to both countries, including strengthening emergency response capacities, addressing emerging infectious disease threats, combatting the spread of antimicrobial resistance, institutionalizing health security, and promoting R&D and innovation.
Source : CSIS. Read full article here.